1-3 of 3
Ruby H. P. Law
Close
Sort by
Journal Articles

Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains

Aleksandr Shamanaev, Ivan Ivanov, Mao-Fu Sun, Maxim Litvak, Priyanka Srivastava, Bassem M. Mohammed, Rabia Shaban, Ashoka Maddur, Ingrid M. Verhamme, Owen J. T. McCarty, Ruby H. P. Law, David Gailani
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3142–3154.
https://doi.org/10.1182/bloodadvances.2021005976
Published: 2022
Includes: Supplemental data
Journal Articles

Tranexamic acid is an active site inhibitor of urokinase plasminogen activator

Guojie Wu, Blake A. Mazzitelli, Adam J. Quek, Matthew J. Veldman, Paul J. Conroy, Tom T. Caradoc-Davies, Lisa M. Ooms, Kellie L. Tuck, Jonathan G. Schoenecker, James C. Whisstock, Ruby H. P. Law
Journal: Blood Advances
Blood Adv (2019) 3 (5): 729–733.
https://doi.org/10.1182/bloodadvances.2018025429
Published: 2019
Includes: Supplemental data
Journal Articles

X-ray crystal structure of plasmin with tranexamic acid–derived active site inhibitors

Ruby H. P. Law, Guojie Wu, Eleanor W. W. Leung, Koushi Hidaka, Adam J. Quek, Tom T. Caradoc-Davies, Devadharshini Jeevarajah, Paul J. Conroy, Nigel M. Kirby, Raymond S. Norton, Yuko Tsuda, James C. Whisstock
Journal: Blood Advances
Blood Adv (2017) 1 (12): 766–771.
https://doi.org/10.1182/bloodadvances.2016004150
Published: 2017
Includes: Supplemental data